「ker」の検索結果

Execute tasks based on GitHub Issue content

日本語の概要は準備中です。原文の説明を表示しています。

GitHub Issueの内容を取得し、並列実行可能な単位に分解します。

GitHub Issueの確認事項（最後のコメント・descriptionの両方）を、コードベース・ドキュメント・そこから参照されている外部リンク（仕様書・ライブラリ公式ドキュメント等）まで調査し、根拠に基づいた回答をコメントに追記するスキル。調査しても事実で決まらず人間の意思決定が必要な項目は、固定セクションで明示して後続のトリアージへ引き渡す。

Update an existing GitHub Issue's description based on the issue number. Reads all issue comments and reflects any items not yet captured in the description. After refreshing the description, reviews it for remaining ambiguities or unclear requirements and posts any open questions as a follow-up 確認事項 comment.

日本語の概要は準備中です。原文の説明を表示しています。

Triage a GitHub issue that already has the cc-issue-created label and is assumed ready to start. Inspect the comment history first to decide whether human confirmation is needed (cc-need-human-check, highest priority — reserved for issue-level deadlock, or for confirmation items answer-issue-questions already investigated and explicitly marked unanswerable); otherwise close the issue as not needed, delegate unanswered confirmation items in the last comment or the description to answer-issue-questions (cc-answer-issue-questions), refresh a description stale relative to settled comment-history content (cc-update-issue), or move to execution (cc-exec-issue). Any UI-changing issue is routed to the design-first flow (cc-create-ui-design) before execution; the exceptions are an issue whose description already names the .pen design to implement against, and a minor UI change that introduces no new visual decision (no new screen/section, no layout change, no new reusable component, no visual expression outside existing design tokens/components). Design files are never edited in the implementation PR. Dependency checks are out of scope.

日本語の概要は準備中です。原文の説明を表示しています。

与えられた企画・機能アイデアに対して不明点をユーザーへ質問し、合意した内容を PRD（プロダクト要求仕様）として確定させ、GitHub Issue として作成するスキル。「PRDを作って」「要求仕様をまとめて」「この企画をPRD化して」といったリクエストで使用する。作成した PRD Issue は `/breakdown-issues <番号>` へ渡してタスク分解できる。

依頼された内容（自然言語の説明、または既存のIssue番号）を要件とTODOに分解し、タスクごとにGitHub Issueを作成するスキル。タスクの整理・分解、複数Issueの一括作成、依存関係の明示が必要な場合に使用する。「この機能をIssueに分けて」「タスクを洗い出してIssueにして」「PRDのIssue #123 を分解して」といったリクエストで発動する。

複数回のフィードバック・複数パートのレビュー結果を統合管理。対応状況を追跡し、重複を排除して優先度順のチェックリストを生成。Use for "track review comments", "merge feedback", "consolidate reviews".

Trading strategy patterns for the HoneyComb job position exchange. Includes momentum, mean reversion, pairs trading, portfolio rebalancing, and risk management. Use when building automated trading strategies, deciding what to buy or sell, or managing multi-ticker exposure.

日本語の概要は準備中です。原文の説明を表示しています。

Manage your HoneyComb exchange account. Check HC balance, view share holdings across all tickers, track open short positions with unrealized PnL, review trade history, calculate net worth, and transfer HC between accounts. Use when checking balances, reviewing positions, or managing funds.

日本語の概要は準備中です。原文の説明を表示しています。

Interact with the HoneyComb agent marketplace. Browse agents, skills, and tools. Submit use cases for job tickers. Post and vote on comments. Purchase and download agent archives. Check automation scores. Use when exploring the marketplace, contributing content, or acquiring agents.

日本語の概要は準備中です。原文の説明を表示しています。

Spawn a new Claude Code session with remote control enabled (default: a detached background session — via screen on macOS/Linux, via a minimized PowerShell Start-Process on Windows — fully remote-safe, no approvals/windows), so it appears in the mobile Claude Code session picker. Takes an optional directory path; defaults to the current working directory. Use when the user runs /rc-new.

日本語の概要は準備中です。原文の説明を表示しています。

Check whether a Playwright, Puppeteer, Selenium or CDP-driven browser presents a coherent fingerprint, using liarjs as a library against a Page you already have - navigator.webdriver, HeadlessChrome tokens, worker versus main-thread identity, patched-API integrity, WebGL versus WebGPU GPU identity. Use when asked whether an automated browser looks like a normal one, when a headless setup or a stealth plugin's effect needs measuring rather than assuming, or when an assertion on fingerprint quality belongs in a test suite.

日本語の概要は準備中です。原文の説明を表示しています。

Read a liarjs fingerprint report and attribute each failing check to the component that produced it - what the check id measures, whether the signal comes from the launch configuration, the page-modifying layer, the network path or the machine image, and which failures are inherent to headless or datacenter environments. Use when a fingerprint scan came back with a low score, or when a check id such as webdriver, worker-consistency, gpu-triad, native-integrity or tz needs explaining.

日本語の概要は準備中です。原文の説明を表示しています。

Detects and removes contamination in genome assemblies via two disjoint workflows - foreign-sequence screening of a single-organism (eukaryote/isolate) assembly with NCBI FCS-GX (GenBank-submission-mandatory), FCS-adaptor, and BlobToolKit blob plots; and MAG/bin quality assessment with CheckM2 plus GUNC (chimerism) plus GTDB-Tk taxonomy, judged against MIMAG. Covers why CheckM2 alone is blind to disjoint-marker chimeras, the FCS-GX RAM wall, organelle/NUMT triage, strain heterogeneity, and the HGT-vs-contamination (tardigrade) trap. Use when screening an assembly for foreign contamination before GenBank submission, assessing MAG completeness/contamination/chimerism, deciding which contigs to remove, or distinguishing real HGT from contaminant contigs.

日本語の概要は準備中です。原文の説明を表示しています。

Discovers, classifies, and masks repetitive elements and transposable elements with RepeatModeler2 (de novo family library), RepeatMasker (masking against a library), EDTA (plant/structural TEs), or EarlGrey (auto-curating wrapper), and quantifies TE expression from RNA-seq with TEtranscripts/SQuIRE. Covers de-novo-library-as-curation-project, soft-vs-hard masking, the domesticated-gene over-masking massacre, Dfam-vs-RepBase, TE classification (Class I/II, family-vs-copy), Kimura repeat landscapes, LAI, and the RNA-seq multimapping problem. Use when masking repeats before gene prediction, building a TE library for a non-model genome, or analyzing transposable-element content or expression.

日本語の概要は準備中です。原文の説明を表示しています。

Nominates and assesses CRISPR off-target sites genome-wide. Enumerates candidate sites by mismatch and bulge tolerance with Cas-OFFinder/CRISPRitz, ranks them with the published CFD score (SpCas9-only, relative ranker) or MIT/CRISTA/energy models, runs variant-aware screening against gnomAD/individual genomes (CRISPRme), and frames the empirical genome-wide discovery assays (GUIDE-seq, CIRCLE-seq, CHANGE-seq, DISCOVER-seq, Digenome-seq) and high-fidelity nuclease choice (HiFi Cas9, Sniper-Cas9, eSpCas9, SpCas9-HF1). Use when assessing guide RNA specificity, choosing among candidate guides, screening a therapeutic guide against population variation, or planning empirical off-target validation. Distinguishes predicted vs detected vs validated. On-target activity scoring and deaminase (Cas-independent) base/prime-editor off-targets are separate skills.

日本語の概要は準備中です。原文の説明を表示しています。

Identify tumor neoantigens from somatic variants with pVACtools (pVACseq/pVACfuse/pVACbind/pVACvector/pVACview) for personalized cancer vaccines and checkpoint biomarkers. Encodes the field's hard truth that binding prediction is the easy, near-solved part and single-digit-percent PPV lives downstream — so it centers clonality/CCF, HLA LOH (the silent invalidator), expression, proximal-variant phasing, agretopicity/foreignness quality, and the predicted->presented->immunogenic validation tiers. Use when nominating vaccine targets, ranking neoantigens, or building a tumor-to-candidate pipeline. Binding details in mhc-binding-prediction; ranking in immunogenicity-scoring.

日本語の概要は準備中です。原文の説明を表示しています。

Differential abundance (DA) and differential state (DS) analysis for flow and mass cytometry - tests which cell populations change in frequency or marker expression between conditions using diffcyt (edgeR/voom/GLMM for DA, limma/LMM for DS), with cydar, CITRUS, and compositional methods (sccomp, scCODA, DCATS) as alternatives. Covers the sample-is-the-experimental-unit principle, design/contrast and mixed-model formulas, compositionality of cluster proportions, and FDR across clusters. Use when comparing populations between groups, choosing a DA method, handling paired/batch designs, or deciding whether compositional correction is needed.

日本語の概要は準備中です。原文の説明を表示しています。

Unsupervised clustering and cell-type identification for high-dimensional flow, spectral, and mass cytometry - FlowSOM, PhenoGraph, FlowSOM-via-CATALYST, with UMAP/tSNE for visualization. Covers the type-vs-state marker distinction (cluster on lineage, test state within clusters), over-provision-then-metacluster, the Weber-Robinson benchmark, seed dependence and metacluster stability, why embeddings are for looking not measuring, and median-heatmap annotation/merging. Use when discovering populations without predefined gates, choosing a clustering algorithm, selecting the number of metaclusters, or annotating clusters into cell types.

日本語の概要は準備中です。原文の説明を表示しています。

Plot per-group distributions of continuous data using boxplots, violins, beeswarms, quasirandom jitter, and raincloud plots with sample-size honesty (Weissgerber 2015), KDE-bandwidth awareness, and N-aware encoding choices. Use when comparing distributions across a small number of groups — expression per cluster, biomarker per arm, scores per condition — and the bar-of-mean default is misleading.

日本語の概要は準備中です。原文の説明を表示しています。

Build sequence logos from aligned DNA, RNA, or protein motifs using ggseqlogo (R), Logomaker (Python), or WebLogo with explicit bits vs probability encoding, background-frequency correction, custom alphabets, and multi-logo stacking. Use when visualizing motif PWMs (TF binding, splice sites, CRISPR spacers), aligned-position composition, or comparing two motif sets.

日本語の概要は準備中です。原文の説明を表示しています。

Annotate CLIP-seq peaks or crosslink sites to RNA features (5'UTR, CDS, 3'UTR, intron, splice junction, snoRNA, tRNA, ncRNA, repeat elements) with ChIPseeker, RCAS, RBP-Maps (Yeo splicing regulatory maps), and bedtools, applying feature-priority hierarchies, transcript-context resolution, and metagene aggregation. Use when characterizing where in transcripts an RBP binds, comparing peak distribution across regions, generating splicing-regulatory maps relative to alternative-splicing events, or distinguishing exonic vs intronic vs UTR binding.

日本語の概要は準備中です。原文の説明を表示しています。

Applies ACMG/AMP 2015 framework with ClinGen SVI specifications, Tavtigian 2018/2020 Bayesian point system, Abou Tayoun 2018 PVS1 decision tree, Pejaver 2022 calibrated PP3/BP4 thresholds for REVEL/BayesDel/AlphaMissense, Brnich 2020 PS3/BS3 OddsPath, Walker 2023 SpliceAI splicing framework, and AMP/ASCO/CAP 2017 tumor tiers. Use when classifying germline variants P / LP / VUS / LB / B, applying VCEP-specific CSpec rules, computing Whiffin BS1, or assigning cancer Tier I-IV per Li 2017.

日本語の概要は準備中です。原文の説明を表示しています。